Eton Pharmaceuticals has named Judith M. Matthews as its new CFO, effective June 1. The appointment is part of a planned leadership transition as James Gruber steps down.
- Judith Matthews appointed EVP of Accounting and Finance effective immediately
- Official transition to CFO role scheduled for June 1, 2026
- James Gruber to step down per planned succession
- Matthews previously served as CFO of Iterum Therapeutics (2015-2026)
- ETON shares closed at $26.97 on the previous trading day
Sign up free to read the full analysis
Create a free account to unlock full AI-curated market articles, personalized alerts, and more.